Stem Cells

Answer: StemCells's phone number is +16*********

Answer: StemCells's official website is https://stemcellsinc.com

Answer: StemCells's revenue is $50 Million to $100 Million

Answer: StemCells's SIC: 2834

Answer: StemCells's NAICS: 621511

Answer: StemCells has 51-200 employees

Answer: StemCells is in Biotechnology

Answer: StemCells contact info: Phone number: +16********* Website: https://stemcellsinc.com

Answer: StemCells, Inc. is currently engaged in clinical development of its HuCNS-SC platform technology (purified human neural stem cells) as a potential treatment for both neurological and retinal disorders. Top-line data from the Company's Phase I/II clinical trial in thoracic spinal cord injury (SCI) showed measurable gains involving multiple sensory modalities and segments, including the conversion of two of seven patients enrolled in the study with complete injuries to incomplete injuries, post-transplant. The Company's PathwayTM Study, a Phase II proof-of-concept trial in cervical SCI is actively enrolling at eight sites and interim data from the first cohort of six patients is anticipated to be forthcoming in Q4 2015. StemCells, Inc. has also completed its Phase I/II clinical trial in GA-AMD. Top-line results from this study show a positive safety profile and favorable preliminary efficacy data related to visual acuity and contrast sensitivity. The Company's RadiantTM Study, a Phase II proof-of-concept trial in GA-AMD is now enrolling at the first of approximately twenty U.S. sites expected to participate. In a Phase I clinical trial in Pelizaeus-Merzbacher disease (PMD), a fatal myelination disorder in children, the Company showed preliminary evidence of progressive and durable donor-derived myelination by MRI.

Answer:

• Twitter
• LinkedIn